Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Raymond James 

5n Plus Inc. diskutieren

5n Plus Inc.

WKN: A0NAH2 / Symbol: FPLSF / Name: 5N Plus / Aktie / Metalle & Bergbau / Small Cap /

24,20 €
-0,98 %

2 0
2
0

5N Plus (OTCMKTS:FPLSF) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Ratings data for FPLSF provided by MarketBeat

Raymond James 
0
Melden Teilen
17.10.25 Buy 124,49 %

5N Plus (FPLSF) is now covered by Scotiabank. They set an "outperform" rating on the stock.
Ratings data for FPLSF provided by MarketBeat

Scotiabank 
0
Melden Teilen
22.06.26 Buy -11,36 %
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

Seaport_Research_Par in Imax Corp. diskutieren
IMAX (IMAX) had its "buy" rating reaffirmed by Seaport Re...
24.06.26
Royal_Bank_of_Canada in Verastem Inc. diskutieren
Verastem (VSTM) had its "outperform" rating reaffirmed by...
24.06.26
Royal_Bank_of_Canada in Canadian Pacific Railway diskutieren, Canadian Pacific City Kansas Ltd.
Canadian Pacific Kansas City (NYSE:CP) (TSE:CP) had its "...
24.06.26
Benchmark_Co_ in Cineverse Corp. diskutieren
Cineverse (CNVS) had its "buy" rating reaffirmed by Bench...
24.06.26
Stifel_Nicolaus in M/a-Com Technology Sol. diskutieren
MACOM Technology Solutions (MTSI) had its price target ra...
24.06.26
Guggenheim in EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (EYPT) had its "buy" rating reaf...
24.06.26
Wedbush in Varonis Systems Inc. diskutieren
Varonis Systems (VRNS) had its "outperform" rating reaffi...
24.06.26
Mizuho in Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by Mizuho...
24.06.26
Mehr anzeigen